【单选题】
Monday, October 17, 15:52
Breaking News....Breaking News....Breaking News
Shares inBrussels-based Roscoe PharmaceuticalsCo. rose sharply today on heavy trading. The rise came afterCEO LeonardBouveier revealed that final tests of a new drug for older patients, those between 65 and 80, had proved more successful than hopeD、
The drug, called Horizon H54, is aimed at aiding memory. Test results showed that it could slow memory loss by as much as 17% in patients if taken regularly and in combination with other prescribed medication.CEOBouveier said the company hoped to launch the drug by January of next year after the current approval process by government regulators is completeD、
Analysts have valued the potential market value for the drug inEurope and NorthAmerica at around billion.
The news means Roscoe has now gotten ahead of its closest competitor, London-basedDevitt Health Group, in this fielD、Devitt is known to have been working on a similar drug for the past eighteen months.
What is the current status of Horizon H54
A、It is being combined with other medicines.
B、It is being prescribed in hospitals.
C、It is being analyzed by officials.
D、It is being marketed through sales groups.
网考网参考答案：C
网考网解析：
这道题的关键词是“Horizon H54”，这个词出现在文章的第二段开头处，所以我们要对照选项，阅读这部分内容。因为每一个选项都含有“it is being”，所以我们要“纵向浏览”它后面的部分。文中写到“the company hoped to launch the drug…after the current approvalprocess by govemment regulators is completed”，即药品在“等待许可”。(C)是对此进行的同义转述，所以是。
document.getElementById("warp").style.display="none";
document.getElementById("content").style.display="block";
查看试题解析出处>>
发布评论 查看全部评论